All Updates

All Updates

icon
Filter
Product updates
ConcertAI launches predictive and GenAI solutions for oncology research
Clinical Trial Technology
May 31, 2024
This week:
M&A
Funding
TravelPerk raises USD 135 million in debt funding for expansion; acquires AmTrav
Travel Tech
Yesterday
Product updates
Apple announces Apple Pay Later shutdown
Buy Now, Pay Later
Jun 17, 2024
Management news
Velo3D appoints Brad Kreger as permanent CEO
Additive Manufacturing
Jun 17, 2024
Partnerships
Perplexity partners with SoftBank for AI search engine promotion in Japan
Generative AI Applications
Jun 17, 2024
Product updates
Runway launches Gen-3 Alpha for generating video clips
Generative AI Applications
Jun 17, 2024
Product updates
Adobe integrates Firefly into Acrobat with chat support across multiple documents in Acrobat AI Assistant
Generative AI Applications
Jun 17, 2024
Funding
Amplify Life raises USD 20 million in Series B to expand product suite
InsurTech: Personal Lines
Jun 17, 2024
Funding
Tinybird raises USD 30 million in Series B funding to improve real-time data analytics platform
Data Infrastructure & Analytics
Jun 17, 2024
Partnerships
The EVERY Company collaborates with Grupo Palacios to develop hen-less omelets
Plant-based Dairy & Egg
Jun 17, 2024
Partnerships
Believer Meats partners with AGWA to propel cultivated meat industry in MENA region
Cell-cultured Meat
Jun 17, 2024
Clinical Trial Technology

Clinical Trial Technology

May 31, 2024

ConcertAI launches predictive and GenAI solutions for oncology research

Product updates

  • AI-powered health and life sciences firm ConcertAI has unveiled its new predictive and GenAI solutions, expansions in partnerships, and a clinical oncology suite designed to enhance research capabilities and support complex clinical study workflows. These solutions aim to provide researchers with enhanced in-depth data analysis facilities, contributing to the creation of new care strategies to improve patient outcomes.

  • The company’s new GenAI solutions include 1) CARA AI, a comprehensive multi-modal data management platform designed to advance research across multiple fields, support collaborations, and manage multi-modal real-world data, and 2) TriaLinQ, a clinical trial screening system (as part of ConcertAI’s oncology quality management platform SmartLinQ) capable of screening 3x more patients than electronic medical records (EMR)-based screening.

  • The Massachusetts-based company offers an oncology-focused Saas platform that incorporates real-world data (RWD) to support drug developers and pharmaceutical companies in expediting drug discovery and development. It reportedly maintains the largest oncology database in the industry, with data gathered from various sources, including the FDA. It also offers clinical trial technology support platforms that assist with clinical trial management specializing in solutions for oncology-related trials.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.